StockData

Prestige Consumer Healthcare vs Perrigo

PBH and PRGO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PBH and PRGO compare

Prestige Consumer Healthcare and Perrigo are about the same size, with market caps of $2.3B and $2.2B.

Prestige Consumer Healthcare grew revenue faster over the last twelve months (−1.4% versus −4.2% for Perrigo).

Prestige Consumer Healthcare keeps more of each dollar of sales as profit, with a net margin of 15.6% compared with −41.9% at Perrigo.

Perrigo pays a dividend yielding 5.5%; Prestige Consumer Healthcare does not pay one.

Prestige Consumer Healthcare scores higher on the StockData Score (12 against 9 for Perrigo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPBHPRGO
Size and price
Market cap$2.3B$2.2B
Share price$48.22$15.76
Change, 1 year−19.6%14.4%
Change, 5 years−14.5%−58.3%
Beta (5Y)0.742.02
Employees8908,100
StockData Score
Total score12 (better)9
Valuation score5 (better)2
Growth score1 (better)0
Performance score4 (better)2
Health score2 (better)1
Dividend score04 (better)
Valuation
P/E13.5×–
P/S2.1×0.5× (better)
P/B1.2×0.9× (better)
EV/EBITDA13.1×–
P/FCF9.7× (better)18.3×
FCF yield10.3% (better)5.5%
Fair value$63.54$17.50
Margin of safety24.1% (better)10.0%
Growth
Revenue growth (TTM)−1.4% (better)−4.2%
Revenue growth, 5Y average2.9% (better)0.79%
Net income growth (TTM)−19.2%–
EPS growth (TTM)−16.2%–
EPS growth, 5Y average3.8%–
Profitability
Gross margin53.5% (better)33.3%
Operating margin26.3% (better)−37.7%
Net margin15.6% (better)−41.9%
FCF margin21.3% (better)2.9%
Return on equity9.1% (better)−49.6%
Return on invested capital8.2% (better)−18.9%
Financial health
Debt / equity1.05 (better)1.31
Net debt / EBITDA5.98–
Current ratio3.23 (better)2.32
Altman Z-score1.60 (better)−0.39
Piotroski F-score44
Dividends and buybacks
Dividend yield–5.5%
Years of dividend growth–11
Dividend growth, 5Y average–5.2%
Buyback yield5.3%–
Shareholder yield5.3%5.5% (better)
Ownership
Held by institutions113%116%
Held by insiders1.4%0.36%
Insider net buying, 12 months−$203K$0 (better)
Short interest, % of float9.1%17.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.